Unknown

Dataset Information

0

Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy.


ABSTRACT: BACKGROUND:Drug-related adverse events (AEs) are reported to be common amongst patients receiving outpatient parenteral antimicrobial therapy (OPAT). However, comparative data regarding intravenous (iv) catheter-related AEs are lacking. OBJECTIVES:To compare drug- and iv catheter-related AEs from a large UK OPAT centre. PATIENTS AND METHODS:We reviewed 544 OPAT episodes [median (IQR) age: 57 (39-71) years, 60% male, 13% with diabetes] with a median (IQR) duration of 7 (2-18) days. Clinically significant drug- and iv catheter-related AEs were calculated as a percentage of OPAT episodes with an AE and also as AEs per 1000 iv drug/catheter days. RESULTS:Drug-related AEs complicated 13 (2.4%) OPAT episodes at 1.7 (95% CI 0.9-2.9) per 1000 drug days. Catheter-related AEs occurred more frequently, complicating 32 (5.9%) episodes at 5.7 (95% CI 4.2-7.9) per 1000 iv catheter days (χ2 test for difference in AE rate: P < 0.001). Non-radiologically guided midline catheters were associated with the most frequent AEs (n = 23) at 15.6 (95% CI 10.3-23.4) per 1000 iv catheter days compared with other types of iv catheters (HR 8.4, 95% CI 2.4-51.9, P < 0.004), and self-administration was associated with a higher rate of catheter-related AEs at 12.0 (95% CI 6.0-23.9) per 1000 iv catheter days (HR 4.15, 95% CI 1.7-9.1, P = 0.007). CONCLUSIONS:Clinically significant iv catheter-related AEs occurred more frequently than drug-related AEs, especially when using non-radiologically guided midline catheters. Regular review of the need for iv therapy and switching to oral antimicrobials when appropriate is likely to minimize OPAT-related AEs.

SUBMITTER: Underwood J 

PROVIDER: S-EPMC6376853 | biostudies-other | 2019 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy.

Underwood Jonathan J   Marks Michael M   Collins Steve S   Logan Sarah S   Pollara Gabriele G  

The Journal of antimicrobial chemotherapy 20190301 3


<h4>Background</h4>Drug-related adverse events (AEs) are reported to be common amongst patients receiving outpatient parenteral antimicrobial therapy (OPAT). However, comparative data regarding intravenous (iv) catheter-related AEs are lacking.<h4>Objectives</h4>To compare drug- and iv catheter-related AEs from a large UK OPAT centre.<h4>Patients and methods</h4>We reviewed 544 OPAT episodes [median (IQR) age: 57 (39-71) years, 60% male, 13% with diabetes] with a median (IQR) duration of 7 (2-18  ...[more]

Similar Datasets

| S-EPMC5848264 | biostudies-literature
| S-EPMC7566523 | biostudies-literature
| S-EPMC5907854 | biostudies-other
| S-EPMC7532659 | biostudies-literature
| S-EPMC6917971 | biostudies-literature
| S-EPMC7270705 | biostudies-literature
| S-EPMC7931831 | biostudies-literature
| S-EPMC6637276 | biostudies-literature
| S-EPMC7990064 | biostudies-literature
| S-EPMC6765349 | biostudies-other